Welcome to our dedicated page for Innovex International SEC filings (Ticker: INVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Innovex International, Inc. filings document formal disclosures for an oil and gas well-products company formed from the Dril-Quip and Innovex Downhole Solutions merger. Recent 8-K reports furnish quarterly results, earnings presentations and non-GAAP reconciliations, while proxy materials cover annual meeting matters, board governance and executive compensation.
The filing record also includes material-event disclosures on common-stock offering agreements by selling stockholders, share repurchase activity under the company's repurchase program, director changes and litigation involving Downhole Well Solutions, LLC, a wholly owned subsidiary, and friction-reduction tools used in directional drilling.
Innovex International, Inc. executive Mark Reddout, President of North America, reported selling 20,000 shares of common stock on January 14, 2026 at $25 per share. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 10, 2025, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). After this transaction, he directly beneficially owned 129,436 shares of Innovex International common stock.
Innovex International, Inc. (INVX) Chief Executive Officer and director Adam Anderson reported selling 13,241 shares of common stock on January 14, 2026. The sale, coded as an open market sale, was executed at a price of $25 per share and was carried out under a Rule 10b5-1 trading plan adopted on March 14, 2025, which is designed to pre-arrange trades. Following this transaction, Anderson directly beneficially owns 498,822 shares of Innovex common stock.
An affiliate of INVX has filed a Form 144 giving notice of a planned sale of 20,000 shares of common stock through UBS Financial Services, Inc. on the NYSE. The filing lists an aggregate market value of $500,000 for these shares, compared with 68,927,791 shares outstanding for the issuer.
The shares to be sold were acquired as a stock award from the issuer on July 3, 2024, in a non-cash transaction described as “N/A” for payment. The approximate date of sale is indicated as January 14, 2026. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
An insider of the issuer filed a Form 144 to potentially sell 13,241 shares of common stock through UBS Financial Services on 01/14/2026 on the NYSE. The filing lists an aggregate market value of $331,025.00 for these shares, compared with 68,927,791 shares outstanding for the issuer’s common stock.
The shares to be sold were originally acquired on 12/31/2016 as a stock award from the issuer, with the full amount of 13,241 shares received on that date. The signer represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
Innovex International, Inc. insider Adam Anderson, who serves as both Director and Chief Executive Officer, reported a stock transaction on 01/02/2026. He had 23,232 shares of Innovex common stock withheld at a price of $22.78 per share, classified under transaction code F, which is typically used for shares withheld to cover taxes. After this withholding related to the release of restricted stock units, Anderson beneficially owns 512,063 shares of Innovex common stock directly.
Innovex International, Inc. chief financial officer Kendal Reed reported an automatic share withholding related to equity compensation. On 01/02/2026, Reed had 8,026 shares of Innovex common stock withheld at a price of $22.78 per share, coded as transaction type "F," which typically reflects shares withheld to cover taxes.
After this tax-withholding event tied to the release of restricted stock units, Reed directly beneficially owned 198,857 shares of Innovex common stock. The filing was made as a single-person Form 4 and is a routine insider ownership update rather than an open-market purchase or sale.
Innovex International, Inc. executive Mark Reddout, President of North America, reported a routine equity award. On 12/15/2025, he received 40 shares of Innovex common stock at a price of $0, as part of a grant of 40 shares to every employee of the company. On the same date, 16 shares were disposed of at $22.77 per share, identified with transaction code "F", indicating shares withheld to cover taxes on the award. After these transactions, Reddout directly beneficially owned 149,436 shares of Innovex common stock.
Innovex International, Inc. disclosed an insider equity transaction by its Chief Financial Officer, Kendal Reed. On 12/15/2025, Reed reported activity in the company’s common stock, including an acquisition coded as an award and a related tax-withholding transaction. One entry shows 40 shares of common stock acquired at $0 per share, with beneficial ownership after the reported transactions at 206,883 shares held directly. Another entry reflects 16 shares disposed of at $22.77 per share, also leaving direct ownership at 206,883 shares.
The explanation states this award represents net shares after tax withholding as part of a grant of 40 shares of stock to every employee of the company. The filing is made by one reporting person in Reed’s capacity as an officer of Innovex International, serving as Chief Financial Officer.
Innovex International, Inc. director and Chief Executive Officer reported a small equity award and related tax withholding. On 12/15/2025, the insider received 40 shares of common stock at a stated price of $0. The filing notes this award reflects the net shares after tax withholding from a grant of 40 shares made to every company employee.
Also on 12/15/2025, 16 shares of common stock were disposed of at $22.77 with a transaction code of “F,” indicating shares withheld to cover taxes on the award. Following these transactions, the insider directly beneficially owns 535,295 shares of Innovex common stock.
Innovex International (INVX): Schedule 13G/A Amendment No. 3 — Brandes Investment Partners, L.P. reported beneficial ownership of 7,658,244 common shares, representing 11.13% of the class as of 09/30/2025. The filer reports 0 shares with sole voting or dispositive power, 4,728,083 with shared voting power, and 7,658,244 with shared dispositive power.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. This filing updates Brandes’s passive ownership position in Innovex.